Sartorius Aktiengesellschaft (FRA:SRT3)

Market Cap	13.24B
Revenue (ttm)	3.44B
Net Income (ttm)	95.60M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	138.48
Forward PE	36.15
Dividend	0.74 (0.34%)
Ex-Dividend Date	Mar 28, 2025

Volume	150,793
Average Volume	136,363
Open	210.00
Previous Close	210.10
Day's Range	209.90 - 217.70
52-Week Range	166.05 - 292.00
Beta	n/a
RSI	43.97
Earnings Date	Jul 22, 2025

About FRA:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 13,528
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SRT3

Financial Performance

In 2024, FRA:SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.